SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-003076
Accepted
2023-10-25 00:15:52
Documents
1
Effectiveness Date
2023-10-24
Registration Form
POS AM
Reference AccNo
0001104659-23-110245

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 607
  Complete submission text file 9999999995-23-003076.txt   1813
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-260146 | Film No.: 231343799
SIC: 2834 Pharmaceutical Preparations